From Amy Harmon’s piece in NYT about how genome sequencing is becoming a luxury item:

Id rather spend my money on my genome than a Bentley or an airplane, said Mr. Stoicescu, 56, a biotechnology entrepreneur who retired two years ago after selling his company. He says he will check discoveries about genetic disease risk against his genome sequence daily, like a stock portfolio.

But while money may buy a full readout of the six billion chemical units in an individuals genome, biologists say the superrich will have to wait like everyone else to learn how the small variations in their sequence influence appearance, behavior, abilities, disease susceptibility and other traits.

I was in someones Bentley once nice car, said James D. Watson, the co-discoverer of the structure of DNA, whose genome was sequenced last year by a company that donated the $1.5 million in costs to demonstrate its technology. Would I rather have my genome sequenced or have a Bentley? Uh, toss up.

He would probably pick the genome, Dr. Watson said, because it could reveal a disease-risk gene that one had passed on to ones children, though in his case, it did not. What is needed, he said, is a Chevrolet genome that is affordable for everyone.

(Thanks, Jim!)

photo: Bentley.com